221 related articles for article (PubMed ID: 32745471)
1. Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis.
Holman SP; Lobo AS; Novorolsky RJ; Nichols M; Fiander MDJ; Konda P; Kennedy BE; Gujar S; Robertson GS
Exp Neurol; 2020 Nov; 333():113430. PubMed ID: 32745471
[TBL] [Abstract][Full Text] [Related]
2. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
3. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen-induced knockdown of the mitochondrial calcium uniporter in Thy1-expressing neurons protects mice from hypoxic/ischemic brain injury.
Nichols M; Pavlov EV; Robertson GS
Cell Death Dis; 2018 May; 9(6):606. PubMed ID: 29789575
[TBL] [Abstract][Full Text] [Related]
5. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.
Craner MJ; Hains BC; Lo AC; Black JA; Waxman SG
Brain; 2004 Feb; 127(Pt 2):294-303. PubMed ID: 14662515
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model.
Singh I; Samuvel DJ; Choi S; Saxena N; Singh AK; Won J
Immunology; 2018 Jul; 154(3):434-451. PubMed ID: 29331024
[TBL] [Abstract][Full Text] [Related]
7. The effect of mitochondrial calcium uniporter and cyclophilin D knockout on resistance of brain mitochondria to Ca
Hamilton J; Brustovetsky T; Brustovetsky N
J Biol Chem; 2021; 296():100669. PubMed ID: 33864812
[TBL] [Abstract][Full Text] [Related]
8. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
9. Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria.
Hamilton J; Brustovetsky T; Rysted JE; Lin Z; Usachev YM; Brustovetsky N
J Biol Chem; 2018 Oct; 293(40):15652-15663. PubMed ID: 30154242
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
[TBL] [Abstract][Full Text] [Related]
11. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
12. Zn
Ji SG; Medvedeva YV; Weiss JH
Exp Neurol; 2020 Mar; 325():113161. PubMed ID: 31881218
[TBL] [Abstract][Full Text] [Related]
13. Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors.
Nichols M; Elustondo PA; Warford J; Thirumaran A; Pavlov EV; Robertson GS
J Cereb Blood Flow Metab; 2017 Aug; 37(8):3027-3041. PubMed ID: 27909264
[TBL] [Abstract][Full Text] [Related]
14. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
[TBL] [Abstract][Full Text] [Related]
15. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T
Cells; 2019 Sep; 8(9):. PubMed ID: 31484369
[TBL] [Abstract][Full Text] [Related]
16. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
17. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Stanojlovic M; Pang X; Lin Y; Stone S; Cvetanovic M; Lin W
PLoS One; 2016; 11(7):e0160158. PubMed ID: 27466819
[TBL] [Abstract][Full Text] [Related]
19. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID
J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
[TBL] [Abstract][Full Text] [Related]
20. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
